Speciated High-Density Lipoprotein Biogenesis and Functionality

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Current Atherosclerosis Reports

• Publication date

  2016-03-23

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s11883-016-0572-7PMID 27005803
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Defects of High-Density Lipoproteins in Coronary Artery Disease Caused by Low Sphingosine-1-Phosphate Content: Correction by Sphingosine-1-Phosphate-Loading.

  2015cited by this paper
• Kinetic and thermodynamic analyses of spontaneous exchange between high-density lipoprotein-bound and lipid-free apolipoprotein A-I.

  2015cited by this paper
• A Retained Secretory Signal Peptide Mediates High Density Lipoprotein (HDL) Assembly and Function of Haptoglobin-related Protein*

  2014cited by this paper
• Setting the course for apoAII: a port in sight?

  2013cited by this paper
• Apolipoprotein M promotes mobilization of cellular cholesterol in vivo.

  2013cited by this paper
• Proteomic diversity of high density lipoproteins: our emerging understanding of its importance in lipid transport and beyond1

  2013cited by this paper
• Human Apolipoprotein A-II Protects Against Diet-Induced Atherosclerosis in Transgenic Rabbits

  2013cited by this paper
• HDL quality or cholesterol cargo: what really matters – spotlight on sphingosine-1-phosphate-rich HDL

  2013cited by this paper
• Multi-dimensional Co-separation Analysis Reveals Protein–Protein Interactions Defining Plasma Lipoprotein Subspecies*

  2013cited by this paper
• Optimized signal peptides for the development of high expressing CHO cell lines

  2013cited by this paper
• Paraoxonase 1 activities, regulation, and interactions with atherosclerotic lesion

  2013cited by this paper
• Interleukin-6 upregulates paraoxonase 1 gene expression via an AKT/NF-κB-dependent pathway.

  2013cited by this paper
• Proteomics investigations of HDL: challenges and promise.

  2012cited by this paper
• Sphingosine 1-Phosphate (S1P) Carrier-dependent Regulation of Endothelial Barrier

  2012cited by this paper
• Novel African Trypanocidal Agents: Membrane Rigidifying Peptides

  2012cited by this paper
• Sphingosine 1-phosphate in coagulation and inflammation

  2011cited by this paper
• Apolipoprotein M binds oxidized phospholipids and increases the antioxidant effect of HDL.

  2011cited by this paper
• Prospective study of coronary heart disease vs. HDL2, HDL3, and other lipoproteins in Gofman's Livermore Cohort.

  2011cited by this paper
• Estrogen upregulates hepatic apolipoprotein M expression via the estrogen receptor.

  2011cited by this paper
• Problems with 'focal segmental glomerulosclerosis'

  2011cited by this paper
• Endothelium-protective sphingosine-1-phosphate provided by HDL-associated apolipoprotein M

  2011cited by this paper
• The trypanolytic factor-mechanism, impacts and applications.

  2010cited by this paper
• High-density lipoprotein determines adult mouse cardiomyocyte fate after hypoxia-reoxygenation through lipoprotein-associated sphingosine 1-phosphate.

  2010cited by this paper
• Proteomic characterization of human plasma high density lipoprotein fractionated by gel filtration chromatography.

  2010cited by this paper
• Speciated human high-density lipoprotein protein proximity profiles.

  2010cited by this paper
• Sphingosine 1-phosphate levels in plasma and HDL are altered in coronary artery disease

  2010cited by this paper
• Sphingosine-1-phosphate in the plasma compartment regulates basal and inflammation-induced vascular leak in mice.

  2009cited by this paper
• Proteomic Analysis of Defined HDL Subpopulations Reveals Particle-Specific Protein Clusters: Relevance to Antioxidative Function

  2009cited by this paper
• Apolipoproteins A-I, A-II and E are independently distributed among intracellular and newly secreted HDL of human hepatoma cells.

  2009cited by this paper
• Apolipoprotein M affecting lipid metabolism or just catching a ride with lipoproteins in the circulation?

  2009cited by this paper
• Sphingosine-1-phosphate as a mediator of high-density lipoprotein effects in cardiovascular protection.

  2008cited by this paper
• Apolipoprotein M associates to lipoproteins through its retained signal peptide

  2008cited by this paper
• Effect of Apolipoprotein M on High Density Lipoprotein Metabolism and Atherosclerosis in Low Density Lipoprotein Receptor Knock-out Mice*

  2008cited by this paper
• The Signal Peptide Anchors Apolipoprotein M in Plasma Lipoproteins and Prevents Rapid Clearance of Apolipoprotein M from Plasma*

  2008cited by this paper
• An ELISA for apolipoprotein M reveals a strong correlation to total cholesterol in human plasma Published, JLR Papers in Press, May 25, 2007.

  2007cited by this paper
• Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL.

  2007cited by this paper
• Speciation of human plasma high-density lipoprotein (HDL): HDL stability and apolipoprotein A-I partitioning.

  2007cited by this paper
• Distinct roles of haptoglobin-related protein and apolipoprotein L-I in trypanolysis by human serum

  2007cited by this paper
• Serum opacity factor unmasks human plasma high-density lipoprotein instability via selective delipidation and apolipoprotein A-I desorption.

  2007cited by this paper
• Formation of high density lipoproteins containing both apolipoprotein A-I and A-II in the rabbit Published, JLR Papers in Press, October 12, 2005.

  2006cited by this paper
• Haptoglobin-related protein is a high-affinity hemoglobin-binding plasma protein.

  2006cited by this paper
• Isolation and characterization of human apolipoprotein M-containing lipoproteins Published, JLR Papers in Press, May 8, 2006.

  2006cited by this paper
• Modulation of paraoxonase (PON1) activity.

  2005cited by this paper
• Apolipoprotein M is required for preβ-HDL formation and cholesterol efflux to HDL and protects against atherosclerosis

  2005cited by this paper
• Plasma factors required for human apolipoprotein A-II dimerization.

  2005cited by this paper
• Remodeling of human plasma lipoproteins by detergent perturbation.

  2005cited by this paper
• Targeted inactivation of hepatic Abca1 causes profound hypoalphalipoproteinemia and kidney hypercatabolism of apoA-I.

  2005cited by this paper
• Intracellular Lipidation of Newly Synthesized Apolipoprotein A-I in Primary Murine Hepatocytes*

  2005cited by this paper
• Restoration of Endothelial Function by Increasing High‐Density Lipoprotein in Subjects With Isolated Low High‐Density Lipoprotein

  2003cited by this paper
• Human plasma high-density lipoproteins are stabilized by kinetic factors.

  2003cited by this paper
• High-density lipoprotein subpopulations in pathologic conditions.

  2003cited by this paper
• The apolipoprotein L gene cluster has emerged recently in evolution and is expressed in human vascular tissue.

  2002cited by this paper
• ApoA-I secretion from HepG2 cells: evidence for the secretion of both lipid-poor apoA-I and intracellularly assembled nascent HDL.

  2002cited by this paper
• Paraoxonase and coronary heart disease.

  2002cited by this paper
• Metabolism of ApoA-I as Lipid-Free Protein or as Component of Discoidal and Spherical Reconstituted HDLs: Studies in Wild-Type and Hepatic Lipase Transgenic Rabbits

  2002cited by this paper
• Proposed lipocalin fold for apolipoprotein M based on bioinformatics and site‐directed mutagenesis

  2001cited by this paper
• The Mechanism of the Remodeling of High Density Lipoproteins by Phospholipid Transfer Protein*

  2001cited by this paper
• Human serum Paraoxonase/Arylesterase's retained hydrophobic N-terminal leader sequence associates with HDLs by binding phospholipids : apolipoprotein A-I stabilizes activity.

  1999cited by this paper
• A Novel Human Apolipoprotein (apoM)*

  1999cited by this paper
• Molecular Cloning and Expression of Lipid Transfer Inhibitor Protein Reveals Its Identity with Apolipoprotein F*

  1999cited by this paper
• Paraoxonase and coronary heart disease.

  1998cited by this paper
• Evidence That Cholesteryl Ester Transfer Protein-mediated Reductions in Reconstituted High Density Lipoprotein Size Involve Particle Fusion*

  1997cited by this paper
• Apolipoprotein L, a New Human High Density Lipoprotein Apolipoprotein Expressed by the Pancreas

  1997cited by this paper
• The lipocalin protein family: structure and function.

  1996cited by this paper
• Remodelling of reconstituted high density lipoproteins by lecithin: cholesterol acyltransferase.

  1996cited by this paper
• Apolipoprotein A-II production rate is a major factor regulating the distribution of apolipoprotein A-I among HDL subclasses LpA-I and LpA-I:A-II in normolipidemic humans.

  1995cited by this paper
• Killing of trypanosomes by the human haptoglobin-related protein.

  1995cited by this paper
• Different reactivities of high density lipoprotein2 subfractions with hepatic lipase.

  1992cited by this paper
• Characterization of disulfide-linked heterodimers containing apolipoprotein D in human plasma lipoproteins.

  1992cited by this paper
• A case-control study of lipoprotein particles in two populations at contrasting risk for coronary heart disease. The ECTIM Study.

  1992cited by this paper
• Physiologic mechanisms for reduced apolipoprotein A-I concentrations associated with low levels of high density lipoprotein cholesterol in patients with normal plasma lipids.

  1992cited by this paper
• Lecithin-cholesterol acyltransferase in the metabolism of high-density lipoproteins.

  1991cited by this paper
• Identification of the disulfide-linked homodimer of apolipoprotein E3 in plasma. Impact on receptor binding activity.

  1991cited by this paper
• Increased apo A-I and apo A-II fractional catabolic rate in patients with low high density lipoprotein-cholesterol levels with or without hypertriglyceridemia.

  1991cited by this paper
• In vivo metabolism of apolipoprotein A-I on high density lipoprotein particles LpA-I and LpA-I,A-II.

  1991cited by this paper
• Study of lipoprotein particles LpAI and LpAI:AII in patients before coronary bypass surgery.

  1990cited by this paper
• Elevated high density lipoprotein cholesterol levels correlate with decreased apolipoprotein A-I and A-II fractional catabolic rate in women.

  1989cited by this paper
• Apolipoprotein A-I containing lipoproteins in coronary artery disease.

  1987cited by this paper
• Distribution and localization of lecithin:cholesterol acyltransferase and cholesteryl ester transfer activity in A-I-containing lipoproteins.

  1986cited by this paper
• Characterization of lipoprotein particles isolated by immunoaffinity chromatography. Particles containing A-I and A-II and particles containing A-I but no A-II.

  1984cited by this paper
• Human apolipoprotein A-I and A-II metabolism.

  1982cited by this paper
• Thermodynamics of lipid-protein association. The free energy of association of lecithin with reduced and carboxymethylated apolipoprotein A-II from human plasma high density lipoprotein.

  1981cited by this paper
• Turnover of apoproteins A-I and A-II of high density lipoprotein and the relationship to other lipoproteins in normal and hyperlipidemic individuals.

  1980cited by this paper
• Identification of the trypanocidal factor in normal human serum: high density lipoprotein.

  1978cited by this paper
• The Tromsø heart-study. High-density lipoprotein and coronary heart-disease: a prospective case-control study.

  1977cited by this paper
• CONTACT INFECTION FROM LIVE VARICELLA VACCINE RECIPIENTS

  1976cited by this paper
• Electron microscopic study on reassembly of plasma high density apoprotein with various lipids.

  1971cited by this paper
• Ischemic Heart Disease, Atherosclerosis, and Longevity

  1966cited by this paper

• Atherosclerosis and wine

  2024cites this paper
• Inverse Correlation of Cholesterol Efflux Capacity with Peripheral Plaque Volume Measured by 3D Ultrasound

  2023cites this paper
• Apolipoprotein E-containing HDL decreases caspase-dependent apoptosis of memory regulatory T lymphocytes

  2023cites this paper
• Efficacy and Safety of Low-Dose Pemafibrate Therapy for Hypertriglyceridemia in Patients with Type 2 Diabetes

  2021cites this paper
• Comparing Data-Independent Acquisition and Parallel Reaction Monitoring in Their Abilities To Differentiate High-Density Lipoprotein Subclasses.

  2019cites this paper
• Effects of Disease-Causing Mutations on the Conformation of Human Apolipoprotein A-I in Model Lipoproteins.

  2018cites this paper
• Quantitative Lipoprotein Subclass and Low Molecular Weight Metabolite Analysis in Human Serum and Plasma by 1H NMR Spectroscopy in a Multilaboratory Trial.

  2018cites this paper
• Current and Emerging Reconstituted HDL-apoA-I and HDL-apoE Approaches to Treat Atherosclerosis

  2018cites this paper
• Emerging roles of HDL in immune function.

  2018cites this paper
• The High Density Lipoprotein Cholesterol Hypothesis Revisited

  2018cites this paper
• The Changing Face of HDL and the Best Way to Measure It.

  2017cites this paper